Open Access Journal on Clinical Diabetes and Endocrinology

Screen Shot 2014-10-08 at 2.01.15 PM

Through a unique publishing collaboration, the University of Michigan and BioMed Central have launched a new open access journal, Clinical Diabetes and Endocrinology, which is now seeking submissions and set to begin publishing in the first quarter of 2015. The journal is led by Editor-in-Chief Meng H. Tan, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan.

Dr. Tan states, “Clinical Diabetes and Endocrinology aims to promote better care for people with diabetes and endocrine diseases by sharing with their health professionals new research and clinical knowledge on various aspects of their diseases. This collaborative academic-private initiative will make the new knowledge readily, freely, and immediately accessible to these health professionals worldwide so it can have a global impact.”

Jasna Markovac, Senior Director, Learning Design and Publishingor Medical School Information Services (MSIS), explains, “The University of Michigan has a history of emphasizing the importance of open scholarship, open access, and open publishing. We encourage faculty to publish in open access journals, but there are very few high quality, reputable ones in the medical field. So the Medical School decided to explore launching a series of open journals in an effort to provide for our faculty, staff and students more alternatives to the traditional subscription-based journals.”

Around the same time, BioMed Central approached Peter Arvan, Division Chief for Metabolism, Endocrinology, and Diabetes, and Director of the Michigan Comprehensive Diabetes Center, about starting a journal. Dr. Markovac, who consults Medical School faculty on alternative publishing models, and Dr. Arvan decided the Biomed Central partnership offered the best of both worlds, combining the model of a traditional peer-reviewed journal with a world-renowned open access publisher.

According to the BioMed Central license agreement, all articles published in the journal will be made available under a Creative Commons Attribution License 4.0 (or under a Creative Commons 1.0 Public Domain Dedication waiver, if required by law). This allows anyone to freely copy and redistribute the material in any medium or format, and also to remix, transform, and build upon the material.

Dr. Arvan, emphasizes, “The University of Michigan is proud to partner with BioMed Central for the launch of Clinical Diabetes and Endocrinology. We hope that this journal will have direct influence on the research and practice within the endocrine subspecialty. The diversity and remarkable credentials of this outstanding editorial board sends a signal that the journal stands for quality in publication to match the quality that we aspire to in our clinical practice.”

Ted Hanss, Chief Information Officer, University of Michigan Medical School, adds, “We are delighted to be partnering with BioMed Central to launch this exciting new open access publication which will allow for critical medical knowledge to be disseminated worldwide without boundaries or restrictions.”

Dr. Markovac concludes, “Everything aligned between our internal Medical School plans and what BioMed Central envisioned. If this goes well, we hope to launch more open access journals for other clinical departments at the Medical School.”

For more information about the journal, open access, or MSIS Health Sciences Publishing Services, please contact Jasna Markovac at

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s